Skip to product information
1 of 6

Nutrex GLP1+ Control, 60 Capsules

Nutrex GLP1+ Control, 60 Capsules

Read reviews →
Also see: Amazon · Google · Reddit
Regular price $34.99 USD
Regular price $59.99 USD Sale price $34.99 USD
Sale Sold out
Shipping calculated at checkout.
Quantity

The full picture

Everything Vyvata knows about this product — the score, the evidence, the FAQ, and where else to find shopper reviews. No hidden data. Every vendor is scored on the same published rubric — no brand can pay for placement. Read the rubric →

38/100
Rejected

Six-dimension breakdown

Evidence
32
Formulation
48
Manufacturing
55
Safety
55
Transparency
42
Sustainability
45

Why this scored 38/100

Nutrex 'GLP1+ Control' branded supplement. Auto-fail: unverified_medical_claim. Same rationale as 21st Century GLP-1: 'GLP-1' as product branding implies mechanistic equivalence to prescription GLP-1 agonists (Ozempic, Wegovy, Mounjaro) that no oral supplement produces at meaningful supplement doses. GLP-1 receptor agonism requires the specific injectable peptide structure of the pharmaceutical drugs. FTC is actively scrutinizing this category ('nature's Ozempic', 'GLP-1 alternative') for deceptive marketing. The underlying ingredients may have modest independent evidence but the branding misrepresents the mechanism.

Auto-fail rule triggered: Unverified medical claim.

A specific medical or physiological benefit claim on the label or marketing is not supported by published clinical evidence in humans. Distinct from disease claims — this covers narrower physiological claims (e.g. 'increases NAD+ by X%', 'boosts immunity') without published RCT support at the actual product dose and formulation. See the full rubric →

Last scored: Full rubric →

Evidence & sources

The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.

Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.

How to read the Evidence dimension

  • 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
  • 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
  • 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
  • 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
  • 0–19: No credible evidence base or unverifiable claims.

Frequently asked questions

Auto-generated from Vyvata's scoring data for this product. For general questions about the store (shipping, returns, wholesale), see the site FAQ.

What is Nutrex GLP1+ Control, 60 Capsules?

Nutrex GLP1+ Control, 60 Capsules is a product from PoorBoySupplements.com, categorized under Weight management & metabolic health in the Supplements vertical. It is scored on the Vyvata Scoring Framework — an independent 6-dimension rubric applied uniformly to every product Vyvata lists.

How does Nutrex GLP1+ Control, 60 Capsules score on the Vyvata rubric?

38/100 overall — Rejected tier (0–49 band). Per-dimension breakdown: Manufacturing 55, Safety 55, Formulation 48, Sustainability 45, Transparency 42, Evidence 32. Scored as of 2026-08-24.

Why did Nutrex GLP1+ Control, 60 Capsules score in the Rejected tier?

Nutrex 'GLP1+ Control' branded supplement. Auto-fail: unverified_medical_claim. Same rationale as 21st Century GLP-1: 'GLP-1' as product branding implies mechanistic equivalence to prescription GLP-1 agonists (Ozempic, Wegovy, Mounjaro) that no oral supplement produces at meaningful supplement doses. GLP-1 receptor agonism requires the specific injectable peptide structure of the pharmaceutical drugs. FTC is actively scrutinizing this category ('nature's Ozempic', 'GLP-1 alternative') for deceptive marketing. The underlying ingredients may have modest independent evidence but the branding misrepresents the mechanism.

What are the strongest and weakest aspects of this product?

Strongest: Manufacturing at 55/100 (third-party testing, GMP compliance, and facility audit status) and Safety at 55/100 (adverse-event profile, interaction risk, and dose ceiling). Weakest: Transparency at 42/100 (dose disclosure vs proprietary blends, and honesty of marketing claims) and Evidence at 32/100 (quality of published RCT support for the active ingredients at the label dose). All six dimensions feed the overall Vyvata score; a weakness on any one dimension pulls the overall down proportionally.

Is Nutrex GLP1+ Control, 60 Capsules third-party tested?

No third-party certifications (NSF, USP, ConsumerLab, or equivalent) were on record at the time of scoring. This affects the Manufacturing dimension score. The manufacturer may test internally or have obtained certification more recently — check the current product label for the most up-to-date information.

Why was this product auto-rejected?

This product triggered the Vyvata auto-fail rule "unverified_medical_claim", which places it in the Rejected tier regardless of its scores on other dimensions. See the full explanation above and the methodology page for the current list of auto-fail rules.

Are there higher-scoring alternatives to Nutrex GLP1+ Control, 60 Capsules?

The top-ranked weight management & metabolic health product in the Vyvata catalog is currently Thorne Berberine Dietary Supplement 1000 mg 60 Capsules at 80/100. See the full ranked list of 218 scored products in this subcategory at https://vyvata.com/pages/best-weight-management-and-metabolic-health-supplements-ranked.

What does the Vyvata score mean?

The Vyvata Scoring Framework rates every listed product 0–100 across six dimensions: Evidence, Formulation, Manufacturing, Safety, Transparency, and Sustainability. Tier bands: Elite 85–100 (top-tier evidence + formulation + manufacturing), Verified 70–84 (strong on most dimensions), Standard 50–69 (solid but with weaknesses called out), Rejected 0–49 (specific failures documented). Rejected products remain listed with reasons. Full methodology at https://vyvata.com/pages/methodology.

Where can I read customer reviews for Nutrex GLP1+ Control, 60 Capsules?

The Vyvata score measures product integrity against a published rubric, not customer sentiment. For customer reviews and community discussion, search external platforms directly: Amazon (https://www.amazon.com/s?k=PoorBoySupplements.com%20Nutrex%20GLP1%2B%20Control%2C%2060%20Capsules),Google(https://www.google.com/search?q=PoorBoySupplements.com%20Nutrex%20GLP1%2B%20Control%2C%2060%20Capsules+reviews),Reddit(https://www.reddit.com/search/?q=PoorBoySupplements.com%20Nutrex%20GLP1%2B%20Control%2C%2060%20Capsules%20review),andTrustpilot(https://www.trustpilot.com/search?query=PoorBoySupplements.com%20Nutrex%20GLP1%2B%20Control%2C%2060%20Capsules).Vyvatadoesnotaggregate,republish,orlicensethosethird-partyreviews.

Customer reviews

Reviews on other platforms

The Vyvata score measures product integrity against a published rubric, not customer sentiment. Vyvata does not aggregate, republish, or license third-party reviews — the links below open search pages on their respective platforms.

All the data we have on this product

Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.

VSF score
38 / 100
Tier
Rejected
Category
Supplements
Subcategory
weight metabolic health
Last scored
Auto-fail rule
unverified_medical_claim
Third-party certifications
None on record at time of scoring
Vendor
PoorBoySupplements.com
Product type
Weight Loss
Tags
PoorBoySupplements.com, Shopify Collective

Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.

View full details